Symposia: Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Acute Myeloid Malignancies, AML, Fundamental Science, Translational Research, Epidemiology, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, CHIP, Clinical Research, Genetic Disorders, Aplastic Anemia, Genomics, Diseases, Treatment Considerations, Biological therapies, Registries, Non-Biological therapies, Myeloid Malignancies, Biological Processes, Molecular biology, Study Population, Human, Transplantation (Allogeneic and Autologous)
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Acute Myeloid Malignancies, AML, Fundamental Science, Translational Research, Epidemiology, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, CHIP, Clinical Research, Genetic Disorders, Aplastic Anemia, Genomics, Diseases, Treatment Considerations, Biological therapies, Registries, Non-Biological therapies, Myeloid Malignancies, Biological Processes, Molecular biology, Study Population, Human, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Room 11
(San Diego Convention Center)
Moderators:
Madhavi Lakkaraja, MD, MPH, Memorial Sloan Kettering Cancer Center
and
Fernanda Gutierrez-Rodrigues, PhD, National Institute of Health
Disclosures:
No relevant conflicts of interest to declare.
This session will feature novel clinical and translational findings related to inherited bone marrow failure and cancer predisposition syndromes.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH